January 31st, 2012
I believe that this could be catastrophic in terms of HIV prevention.

Michael Weinstein, president the AIDS Healthcare Foundation. Weinstein was commenting on drugmaker Gilead’s application for FDA approval to market its HIV treatment medication Truvada as a HIV prevention pill. If Truvada is approved for preventive use, it “would be the first agent indicated for uninfected individuals to reduce the risk of acquiring HIV through sex,” according to a company statement at the time of the filing last month.

Gilead’s application, however, has sparked debate among public health advocates who argue that the wide availability of the drug would discourage safe sex and would, in fact, increase the incidence of HIV.

15 notes·
HIV
AIDS
health
news
  1. leflaneur reblogged this from centerforinvestigativereporting
  2. wind-and-gold reblogged this from centerforinvestigativereporting
  3. jimrehs reblogged this from centerforinvestigativereporting
  4. elizs reblogged this from centerforinvestigativereporting
  5. centerforinvestigativereporting posted this
Loading tweets...

@CIRonline

At The Center for Investigative Reporting, we believe journalism that moves citizens to action is an essential pillar of democracy. Since 1977, CIR has relentlessly pursued and uncovered injustices that otherwise would be hidden from the public eye. Today, we are upholding this legacy and looking forward, working at the forefront of journalistic innovation to produce important stories that make a difference and engage our audiences across the aisle, coast to coast, and worldwide. What drives our work isn't profit – it's impact. Learn more at http://cironline.org/

Networks